| Patient | Albert Einstein |
|---|---|
| Date of birth | 1956-03-14 |
| Identifiers | MRN HR-ET012-SYN; SSN (made up) 000-12-6650 |
| Document date | 2026-03-24 |
| Author | Clementine Ward, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for establishing care for a known abdominal aortic aneurysm: duplex ultrasound, blood pressure, lipids, smoking, and emergency symptoms. [S]
Abdominal aortic diameter, duplex ultrasound: 5 cm (high); Hemoglobin: 14.2 g/dL; White blood cells: 7.4 10*3/uL; Platelets: 232 10*3/uL; Sodium: 140 mmol/L; Potassium: 4.3 mmol/L; Creatinine: 1.02 mg/dL; eGFR: 77 mL/min/1.73 m²; Glucose: 98 mg/dL; Calcium: 9.4 mg/dL; Total cholesterol: 216 mg/dL (high); HDL cholesterol: 44 mg/dL; LDL cholesterol: 142 mg/dL (high); Triglycerides: 148 mg/dL; HbA1c: 5.6%; Urine albumin-to-creatinine ratio: 14 mg/g{creat}; ALT: 24 U/L. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-24 | Body height | 172 | cm | S |
| 2026-03-24 | Body weight | 79 | kg | S |
| 2026-03-24 | Body mass index (BMI) [Ratio] | 26.7 | kg/m2 | S |
| 2026-03-24 | Systolic blood pressure | 146 | mm[Hg] | S |
| 2026-03-24 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 2026-03-24 | Heart rate | 72 | /min | S |
| 2026-03-24 | Respiratory rate | 14 | /min | S |
| 2026-03-24 | Body temperature | 36.7 | Cel | S |
| 2026-03-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-24 | Aorta Diameter by US | 5 | cm | <=3 cm | High | S |
| 2026-03-24 | Hemoglobin [Mass/volume] in Blood | 14.2 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-03-24 | Leukocytes [#/volume] in Blood by Automated count | 7.4 | 10*3/uL | 3.4-9.6 10*3/uL | Normal | S |
| 2026-03-24 | Platelets [#/volume] in Blood by Automated count | 232 | 10*3/uL | 135-317 10*3/uL | Normal | S |
| 2026-03-24 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-24 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-24 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-03-24 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 77 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-24 | Glucose [Mass/volume] in Serum or Plasma | 98 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-03-24 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-03-24 | Cholesterol [Mass/volume] in Serum or Plasma | 216 | mg/dL | <=200 mg/dL | High | S |
| 2026-03-24 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-03-24 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 142 | mg/dL | <=129 mg/dL | High | S |
| 2026-03-24 | Triglyceride [Mass/volume] in Serum or Plasma | 148 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-03-24 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.6 | % | <=5.6% | Normal | S |
| 2026-03-24 | Albumin/Creatinine [Mass Ratio] in Urine | 14 | mg/g{creat} | <=30 mg/g{creat} | Normal | S |
| 2026-03-24 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 7-55 U/L | Normal | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet by mouth each morning | Oral route | 2025-05-20 | active | S |
| Losartan 50 mg oral tablet, one tablet daily | One tablet by mouth each morning | Oral route | 2026-03-24 to 2026-04-21 | completed | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet by mouth each evening | Oral route | 2026-03-24 | active | S |
| Nicotine 14 mg/24 hour transdermal patch, one patch daily | Apply one new patch each morning | Topical route | 2026-03-24 to 2026-07-14 | completed | S |
| Nicotine 2 mg lozenge as needed for cravings | Dissolve one lozenge in the mouth for a craving, no more often than every 2 hours and no more than 20 a day | Oral route | 2026-03-24 to 2026-09-22 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Infrarenal abdominal aortic aneurysm, 5.0 cm by duplex ultrasound, found and wrapped at a prior exploratory laparotomy; under surveillance below the repair threshold | active | confirmed | I71.43 | S — Synthetic modern coding anchored to the documented aneurysm found and wrapped at his exploratory laparotomy; the diameter and all surveillance are synthetic. |
| Essential hypertension | active | confirmed | I10 | S — Synthetic risk factor in the modern frame; no historical blood pressure is documented in the cited sources. |
| Nicotine dependence, pipe tobacco | active | confirmed | F17.290 | S — Synthetic modern coding anchored to his documented pipe smoking. |